The Street/ Hemispherx ATM Withdrawals Raise A Red Flag
PHILADELPHIA (TheStreet) -- Red flag alert: Hemispherx Biopharma (HEB) is selling stock stealthily ahead of December's Ampligen FDA advisory panel.
No rant, just a warning. Hemispherx used a Friday night SEC filing to disclose the sale of 10.9 million shares of stock at an average price of 92 cents per share. After expenses and commissions, Hemispherx net $9.5 million
The Street is just an entertainment company, you think they would give out free advice on how to get rich, they sell snake oil, everything they promote or demote is just fairy dust. sometime they get it right and most of the time they are wrong, if they were that smart, they would be rich and retired. Think about it. Read their fine print.If they were for real, they would have so many lawsuits against them for giving false information.
"You mean, Hemispherx shouldn't be raising money now if the company has confidence in Ampligen?
Exactly. An FDA advisory panel is scheduled to review the chronic fatigue syndrome drug Ampligen on Dec. 20. Presumably, a positive panel vote will push Hemispherx shares much higher than where they trade today. Yet, Hemispherx is rushing to raise money now. That's not a good sign." - A.F. The Street
Well then, why did Sarepta Pharmaceuticals raise $ 40 million ?
After all, A.F. The Street wants us to believe they're about to get approval early 2013.
And unlike Hemispherx, they didn't announce it, they just did it, then published a press release.
How do you like them apples ?
And it gets better, 2 weeks in, it turns out the Military drops all funds for their Ebola program.
Talk about showing confidence.
How does one sell a stock stealthily by announcing you are doing it? You know that many biotech companies with ZERO revenue raise funds leading up to catalyst right? Good business practice. If they didn't, far more than 50% of rejected companies would file for bankruptcy because there first NDA was rejected.